Menu

Innovative Medicine Initiative

CANCER - ID: Cancer treatment and monitoring
PREFER - Patient Preferences in benefit risk assessments during the drug life cycle
  • Principal investigator: Silvia Novello
  • department of Oncology
LITMUS - Liver Investigation: Testing Marker Utility in Steatohepatitis
  • Principal investigator: Elisabetta Bugianesi
  • Department of Medical Sciences
  • Participant EU contribution: 365.160,75
  • Participant costs: 415.160,75
  • Start date: 1st November 2017
  • End date: 31st October 2022
  • Project information on CORDIS
HARMONY - Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY - Sofia ref.: 116026
  • Principal investigator: Mario Boccadoro
  • Department of Molecular Biotechnology and Health Sciences
  • Participant EU contribution: 149.613,00
  • Start date: 1st January 2017
  • End date: 31st December 2021
  • Project information on CORDIS
CARDIATEAM - CARdiomyopathy in type 2 DIAbetes mellitus
  • Principal investigator: Giuseppe Matullo
  • Department of Medical Sciences
  • Participant EU contribution: 407.616,25
  • Participant costs: 470.116,25
  • Start date: 1st May 2019
  • End date: 29th February 2024
  • Project information on CORDIS